Skip to content
CustomCells

CustomCells

ClimateTech·Germany·Exited 2025·Held 3yr
Entry
2022
Hold
3yr
Exit
2025

Who owns CustomCells?

CustomCells is a German ClimateTech company, now owned by ABACON and SALVIA family office consortium, which acquired it in 2025 from Porsche Ventures, 468 Capital and WF World Fund Management.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
WF World Fund Management
Most recent investor
WF World Fund Management
World Fund I · 2021 · VC
4 ownership periods · full history below

Key facts

HQGermany
SectorClimateTech
StatusActive
Key takeaways
  • ·Fully exited in 2025 to Family office consortium led by ABACON and SALVIA.
  • ·Average hold across 4 realized cycles: 6 years.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

4 ownership periods · co-invest detected

Exited
Last exited in 2025 to ABACON and SALVIA family office consortium.
Co-invest · 4 holders · 2013 · 2025
IFB Innovationsstarter
2013 · 2025(12yr) · Innovationsstarter Fonds Hamburg I · 2012 · VC
Secondary · to Family office consortium led by ABACON and SALVIA

IFB Innovationsstarter sold CustomCells to Family office consortium led by ABACON and SALVIA in 2025 after 12 years.

468 Capital
468 CapitalExited 2025
2021 · 2025(4yr) · 468 Capital Fund I · 2020 · VC
Trade Sale · to ABACON and SALVIA family office consortium

468 Capital sold CustomCells to ABACON and SALVIA family office consortium in 2025 after 4 years.

Porsche Ventures
Porsche VenturesExited 2025
2021 · 2025(4yr) · Porsche Ventures Balance-Sheet Vehicle · 2016 · Evergreen
Trade Sale · to ABACON Capital

Porsche Ventures sold CustomCells to ABACON Capital in 2025 after 4 years.

WF World Fund Management
2022 · 2025(3yr) · World Fund I · 2021 · VC
Trade Sale · to Family-office consortium (ABACON, SALVIA)

WF World Fund Management sold CustomCells to Family-office consortium in 2025 after 3 years.

Questions

Who owns CustomCells?

CustomCells is now owned by ABACON and SALVIA family office consortium, which acquired it in 2025 from Porsche Ventures, 468 Capital and WF World Fund Management.

When did ABACON and SALVIA family office consortium acquire CustomCells?

ABACON and SALVIA family office consortium acquired CustomCells in 2025, buying from Porsche Ventures, 468 Capital and WF World Fund Management.

Who did CustomCells sell to?

IFB Innovationsstarter sold CustomCells to Family office consortium led by ABACON and SALVIA in 2025 (Secondary). Porsche Ventures sold CustomCells to ABACON Capital in 2025 (Trade Sale). 468 Capital sold CustomCells to ABACON and SALVIA family office consortium in 2025 (Trade Sale).

Who has owned CustomCells over time?

CustomCells has been through 4 private-equity ownership periods: IFB Innovationsstarter · via Innovationsstarter Fonds Hamburg I · 2013–2025 · sold to Family office consortium led by ABACON and SALVIA · (Secondary); Porsche Ventures · via Porsche Ventures Balance-Sheet Vehicle · 2021–2025 · sold to ABACON Capital · (Trade Sale); 468 Capital · via 468 Capital Fund I · 2021–2025 · sold to ABACON and SALVIA family office consortium · (Trade Sale); WF World Fund Management · via World Fund I · 2022–2025 · sold to Family-office consortium · (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue